SightfileU.S. market data from official filings

Companies › SLGL

Sol-Gel Technologies Ltd (SLGL)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001684693 · EDGAR filings · Updated 2026-07-15

Sol-Gel Technologies Ltd (SLGL) has reported institutional ownership of 45.0%, with 20 institutional managers holding positions valued at $99.4M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
45.0%
Institutional managers
20
Reported 13F value
$99.4M
Insider activity
25 trans.
$6.74M net buying
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Sol-Gel Technologies Ltd has 20 institutional holders and institutional ownership of 45.0%.

Insider activity

Insiders reported 25 transactions (25 buys, 0 sells) across 6 reporting insiders, with a net reported value of $6.74M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-03-19 (recurring since 2026-03-19) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ZENTALIS PHARMACEUTICALS INC (ZNTL) · COHERUS ONCOLOGY INC (CHRS) · FENNEC PHARMACEUTICALS INC (FENC) · PEPGEN INC (PEPG) · ORCHESTRA BIOMED HLDGS INC (OBIO) · KARYOPHARM THERAPEUTICS INC (KPTI)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.